Upper Gastrointestinal Adverse Events and Cyclical Etidronate

The American Journal of Medicine - Tập 103 - Trang 462-467 - 1997
Tjeerd van Staa1, Lucien Abenhaim2,3, Cyrus Cooper4
1Procter & Gamble Pharmaceuticals, Lovett House, Lovett Road, Staines, United Kingdom
2Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
3Center for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Canada
4Medical Research Council Environmental Epidemiology Unit, Southampton University Hospital, Southampton, United Kingdom

Tài liệu tham khảo

Adami, 1996, Adverse effects of bisphosphonates, Drug Safety., 14, 158, 10.2165/00002018-199614030-00003 Papapoulos, 1996, Bisphosphonates: pharmacology and use in the treatment of osteoporosis, 419 Abdelmalek MF, Douglas DD. Alendronate-induced ulcerative esophagitis. Am J Gastroenterol. 1996;91:1282–1283 Letter. Maconi, 1995, Multiple ulcerative esophagitis caused by alendronate, Am J Gastroenterol., 90, 1889 de Groen, 1996, Esophagitis associated with the use of alendronate, NEJM., 335, 1016, 10.1056/NEJM199610033351403 Naylor G, Davies MH. Esophageal stricture associated with alendronic acid. Lancet. 1996;348:1030–1031 Letter. Sorrentino D, Trevisi A, Bernardis V, et al. Esophageal ulceration due to alendronate. Endoscopy. 1996;28:529. Letter. Nightingale, 1996, From the Food and Drug Administration, JAMA., 275, 1453, 10.1001/jama.275.8.585 1996, Current Problems in Pharmacovigilance., 22, 5 Hall, 1992, Pharmacoepidemiology using a UK Database of Primary Care Records, Pharmacoepidemiol Drug Saf., 1, 33, 10.1002/pds.2630010108 Lis, 1995, The Vamp research multi-purpose database in the U.K., J Clin Epidemiol., 48, 431, 10.1016/0895-4356(94)00137-F Mann, 1992, Research implications of computerized primary care, Post Marketing Surveillance., 5, 259 Hollowell, 1994 Anonymous, 1996 Jick, 1991, Validation of information recorded on general practitioner based computerised data resource in the United Kingdom, BMJ., 302, 766, 10.1136/bmj.302.6779.766 Jick, 1992, Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom, Pharmacoepidemiol Drug Saf., 1, 347, 10.1002/pds.2630010607 Nazareth, 1993, Accuracy of diagnosis of psychosis on general practice computer system, BMJ., 307, 32, 10.1136/bmj.307.6895.32 van Staa, 1994, The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions, Pharmacoepidemiol Drug Saf., 3, 15, 10.1002/pds.2630030106 Garcia Rodriguez, 1994, Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs, Lancet., 343, 769, 10.1016/S0140-6736(94)91843-0 van Staa, 1994, A study of the effects of misclassification due to the time-window design in pharmacoepidemiologic studies, J Clin Epidemiol., 47, 183, 10.1016/0895-4356(94)90023-X Kleinbaum, 1982 Rothman, 1986 Breslow, 1987 Kramer, 1988 Heaney, 1991, How do we know what we know? The randomized controlled trial revisited, J Bone Miner Res., 6, 103, 10.1002/jbmr.5650060202 Heaney, 1991, How can we tell if a treatment works? Further thoughts on the randomized controlled trial, Osteoporosis Int., 1, 215, 10.1007/BF03187465 Kramer, 1984, Scientific challenges in the application of randomized trials, JAMA., 252, 2739, 10.1001/jama.1984.03350190041017 1996 Geddes, 1994, Bisphosphonates: structure-activity relationships and therapeutic implications, 8, 265